Peter Harwin is a Managing Member at Fairmount Funds Management. See contact routes.
Peter Harwin is a Managing Member at Fairmount Funds Management, a healthcare-focused investment firm he co-founded in 2016 in West Conshohocken, Pennsylvania, after previously serving on the investment team at Boxer Capital within the Tavistock Group. Fairmount executes strategic equity investments across public and private biotechnology markets, targeting emerging life sciences organizations with differentiated therapeutics, strong research pipelines, and experienced management teams. The firm’s typical check size includes significant rounds such as a $150.0 million Series A investment in Korsana Biosciences in February 2026, though specific lead versus follow behavior is not explicitly detailed in available sources. Notable portfolio companies include Korsana Biosciences, Apogee Therapeutics (where Harwin serves as an Independent Director), Cogent Biosciences (where he chairs the board), and Viridian Therapeutics. Harwin holds board roles at multiple Nasdaq-listed biotech firms, including Spyre Therapeutics, reflecting a deep operational involvement in the portfolio. There is no publicly available distinctive point of view or published writing by
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Philadelphia.
Investors like Peter Harwin · Full investor directory · Investor access · Company funding database